Prosecution Insights
Last updated: July 17, 2026
Application No. 18/260,386

METHOD FOR MODIFYING ANIMAL HAIR

Final Rejection §103
Filed
Jul 05, 2023
Priority
Jan 07, 2021 — JP 2021-001597 +1 more
Examiner
THOMPSON, CAMIE S
Art Unit
1786
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Mitejima Chemical Co. Ltd.
OA Round
2 (Final)
74%
Grant Probability
Favorable
3-4
OA Rounds
4m
Est. Remaining
84%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
982 granted / 1334 resolved
+8.6% vs TC avg
Moderate +10% lift
Without
With
+10.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
45 currently pending
Career history
1383
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
63.6%
+23.6% vs TC avg
§102
16.8%
-23.2% vs TC avg
§112
5.9%
-34.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1334 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicant’s amendment and accompanying remarks filed April 28, 2026 are acknowledged. Examiner acknowledges amended claim 1. Examiner acknowledges cancelled claims 2-4, and 7. The rejection of claims 1-10 under 35 U.S.C. 103 as being unpatentable over Jinsong et al., GB2483886 in view of Kleen et al., DE19945487 is overcome by Applicant’s amendment. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 5-6 and 8-10 are rejected under 35 U.S.C. 103 as being unpatentable over Griffin et al., U.S. pre Grant Publication 2003/0154555 in view of Jinsong et al., GB2483886. Regarding claim 1, Griffin discloses a method of treating fibrous textile good with an enzyme such as transglutaminase [abstract and 0001]. Paragraph 0089 discloses a pre-treatment with a reducing agent such as sodium sulfite [sulfite salt]. Example 5 of Griffin discloses an enzymatic treatment comprising transglutaminase with casein [a protein]. Griffin is silent to the reduction treatment under a neutral or weakly alkaline condition of a pH of 7 to 9 and performed at a temperature of 70 º to 95 ºC for 10 to 120 minutes. Jinsong discloses the treatment of wool [animal hair] [page 1, paragraph 0001 and 0004]. Paragraph 0001 of page 4 of Jinsong discloses wool fiber treated with reducing agent sodium sulphite [sulphite salt] in a buffer solution that is adjusted to pH 8 [weakly alkaline] at 80-85 °C for 10 minutes. Additionally, Jinsong discloses an enzymatic treatment [page 4, paragraph 0001]. Page 1, first paragraph of Jinsong discloses treatment of wool to impart shrink resistance. Griffin and Jinsong are analogous art in that both references are directed to the treatment of animal hair such as wool with a reducing agent and an enzymatic process. One of ordinary skill in the art before the effective filing date of the invention would utilize the reduction treatment process of Jinsong for the benefit of enhanced shrink resistance. Regarding claim 5, paragraphs 0044-0045 of Griffin discloses that the transglutaminase incorporates active agents such as casein and collagen [water soluble protein]. Regarding claims 6 and 9-10, paragraph 0001 of Griffin discloses wool or animal hair. Regarding claim 8, Example 5 discloses that the enzymatic treatment is performed with transglutaminase and casein at 37 ºC for 2.0 hours [120 minutes]. Response to Arguments Applicant’s arguments with respect to the present claims have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. Applicant amended the claims to a combination that has not been previously presented. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to CAMIE S THOMPSON whose telephone number is (571)272-1530. The examiner can normally be reached 8:30 am - 5:30 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Boyd, can be reached at 571-272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CAMIE S THOMPSON/Primary Examiner, Art Unit 1786
Read full office action

Prosecution Timeline

Jul 05, 2023
Application Filed
Jul 05, 2023
Response after Non-Final Action
Jul 07, 2023
Response after Non-Final Action
Nov 30, 2023
Response after Non-Final Action
Feb 02, 2026
Non-Final Rejection mailed — §103
Apr 28, 2026
Response Filed
Jul 07, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12679066
LAMINATE AND METHOD FOR USING LAMINATE
3y 4m to grant Granted Jul 14, 2026
Patent 12668031
ADDITIVE MANUFACTURING USING CONTINUOUS-FIBER REINFORCED COMPOSITES WITH GRAPHENE
2y 5m to grant Granted Jun 30, 2026
Patent 12649983
HYDRO-PATTERNED NONWOVEN AND METHOD OF MAKING THE SAME
4y 1m to grant Granted Jun 09, 2026
Patent 12635468
HOLDING TOOL AND MANUFACTURING METHOD
4y 1m to grant Granted May 19, 2026
Patent 12630474
FORMALDEHYDE-FREE BINDER COMPOSITIONS AND METHODS OF MAKING THE BINDERS UNDER CONTROLLED ACIDIC CONDITIONS
3y 0m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
74%
Grant Probability
84%
With Interview (+10.3%)
3y 5m (~4m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1334 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month